Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.020
-0.040 (-3.77%)
At close: Jul 24, 2026, 4:00 PM EDT
1.040
+0.020 (1.96%)
After-hours: Jul 24, 2026, 7:12 PM EDT
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.56 million as of July 24, 2026. Its market cap has decreased by -65.76% in one year.
Market Cap
3.56M
Enterprise Value
-6.00M
1-Year Change
-65.76%
Ranking
Category
Stock Price
$1.02
ChartMarket Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.88M to $3.56M, a decrease of -39.49%. That is a compound annual growth rate of -5.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.56M | 44.35% |
| Dec 31, 2025 | 2.46M | -28.01% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 4.32M |
| PMGC Holdings | 4.31M |
| Revelation Biosciences | 4.26M |
| Ensysce Biosciences | 4.01M |
| FibroBiologics | 3.97M |
| 60 Degrees Pharmaceuticals | 3.96M |
| Galmed Pharmaceuticals | 3.65M |
| Genprex | 3.60M |